Delving into the Latest Updates on Idorsia (Beijing) Pharmaceuticals Co., Ltd. with Synapse

Overview

Tags

Immune System Diseases

Digestive System Disorders

Skin and Musculoskeletal Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

P2Y12 receptor(Purinergic receptor P2Y12)	1
S1PR1(Sphingosine 1-phosphate receptor Edg-1)	1

[Translation] A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for preventing all-cause mortality and treating acute myocardial infarction in subjects with a recent history of acute myocardial infarction

本研究的主要目的是评估有急性心肌梗死（AMI）复发风险的受试者发生提示 AMI 症状后自行给予 selatogrel 的临床有效性。次要目的是评估自行给予 selatogrel 的安全性。其他目的是评估治疗策略的有效性，该策略有赖于受试者在出现疑似 AMI 症状时做出恰当、快速的反应。

[Translation]

The primary objective of this study was to evaluate the clinical effectiveness of self-administered selatogrel in subjects at risk for recurrent acute myocardial infarction (AMI) after the onset of symptoms suggestive of AMI. Secondary objectives were to evaluate the safety of self-administered selatogrel. Other objectives were to evaluate the effectiveness of a treatment strategy that relies on subjects responding appropriately and rapidly to symptoms suggestive of AMI.

Start Date01 Mar 2024

Sponsor / Collaborator

Idorsia Ltd.

[+3]

100 Clinical Results associated with Idorsia (Beijing) Pharmaceuticals Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Idorsia (Beijing) Pharmaceuticals Co., Ltd.

Login to view more data

100 Deals associated with Idorsia (Beijing) Pharmaceuticals Co., Ltd.

Login to view more data

100 Translational Medicine associated with Idorsia (Beijing) Pharmaceuticals Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Application

1

Phase 3 Clinical

Login to view more data